JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases

NCT06586866 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Triple Negative Breast Cancer (TNBC)
Brain Metastasases

Interventions

DRUG: JK-1201I

Sponsor

JenKem Technology Co., Ltd.